Introduction

Waring, Justin; Denis, Jean‐Louis; Pedersen, Anne Reff; Tenbensel, Tim

doi:10.1007/978-3-030-82696-3_1

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of patients infected with COVID-19 resulted in an influx to hospitals, with health systems facing unprecedented strain [1]. Hospitals worldwide had to rapidly reorientate health services and implement new models of care to cope with increased service demands [2,3]. These models include emergency department avoidance for highrisk patients, e.g., cancer patients and patients with cardiovascular disease [4][5][6][7][8].…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Patients’ Medication Management during Transition of Care from Hospital to Virtual Care: A Cross-Sectional Survey and Audit

Hattingh,

Edmunds,

Buksh

et al. 2023

Pharmacy

View full text Add to dashboard Cite

Background: Virtual models of care were implemented to ease hospital bed pressure during COVID-19. We evaluated the medication management of COVID-19 patients transferred to virtual models of care. Method: A retrospective audit of COVID-19 patients transferred from inpatient units to virtual care during January 2022 and surveys from patients transferred during December 2021–February 2022 was carried out. Results: One hundred patients were randomly selected: mean age 59 years (SD: 19.8), mean number of medicines at admission 4.3 (SD: 4.03), mean length of virtual ward stay 4.4 days (SD: 2.1). Pharmacists reviewed 43% (43/100) of patients’ medications during their hospital stay and provided 29% (29/100) with discharge medicine lists at transfer. Ninety-two (92%) patients were prescribed at least one new high-risk medicine whilst in hospital, but this was not a factor considered to receive a pharmacist medication review. Forty patients (40%) were discharged on newly commenced high-risk medicines, and this was also not a factor in receiving a pharmacist discharge medication list. In total, 25% of patient surveys (96/378) were returned: 70% (66/96) reported adequate medicine information at transfer and 55% (52/96) during the virtual model period. Conclusion: Patient survey data show overall positive experiences of medication management and support. Audit data highlight gaps in medication management during the transfer to a virtual model, highlighting the need for patient prioritisation.

show abstract